InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Robin Sherrington, Directeur Exécutif. Officer active across 2 companies, notably Xenon Pharmaceuticals Inc.. In total, 5 filings have been published. Activity tracked since 28 May 2021. The latest transaction was filed on 7 March 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Robin Sherrington
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
1,234 股@ US$9.8519.3% 占其流量Common SharesSEC:0000950170-24-028795:0
8,398 股0Common SharesSEC:0000950170-24-000304:0
17,488 股@ US$2.6780.7% 占其流量Common SharesSEC:0001209191-22-048508:0
1,234 股@ US$3.679.7% 占其流量Common SharesSEC:0001209191-22-017318:0
12,345 股@ US$3.7690.3% 占其流量Common SharesSEC:0001209191-21-036802:0
5 条申报中的 5 条
About Robin Sherrington
Robin Sherrington is Executive Vice President of Strategy and Innovation at Xenon Pharmaceuticals Inc. She is responsible for strategic leadership and innovation within the company, contributing to its development.
